Priority Healthcare operates pharmacies and related businesses in Alabama and Mississippi. It allegedly billed insurance companies for Roche’s glucose test strips — used by patients with diabetes to test their blood sugar levels — that either weren’t shipped to patients or cost more than the supplies they received, AL.com reported. Employees of Priority Healthcare allegedly then sought rebates from Roche.
Roche paid $30 million to $32 million in fraudulent rebates to Priority Healthcare, court documents show.
Witnesses from Priority Healthcare testified that proceeds from the scheme were kept in shell company accounts, according to AL.com.
Roche’s attorneys claimed that Priority Healthcare’s owners, Phillip and Konie Minga, led the scheme. The company allegedly shifted orders between various pharmacies to hide evidence of fraud, AL.com reported.
Priority Healthcare is banned from purchasing or selling Roche’s Accu-chek test strips.
Read the full article here.
More articles on pharmacy:
FDA vaccine committee votes to endorse J&J COVID-19 vaccine
US to tell states their vaccine allotments months in advance
FDA allows Pfizer vaccines to be stored at higher temperatures
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
